Medicine & Life Sciences
Portugal
100%
Pulmonary Aspergillosis
41%
Serogroup
36%
tazobactam drug combination ceftolozane
34%
Intensive Care Units
32%
Lymphogranuloma Venereum
31%
Microbiology
30%
Vaccines
29%
Invasive Pulmonary Aspergillosis
28%
Genotype
28%
Ribotyping
27%
Pseudomonas aeruginosa
27%
Aspergillus fumigatus
26%
Pneumococcal Infections
25%
Candida
25%
Vancomycin
25%
Fungi
24%
Microbial Drug Resistance
24%
Middle East
24%
Clostridium difficile
23%
Chlamydia trachomatis
22%
Kidney
21%
North America
21%
Kidney Transplantation
20%
Cross Infection
19%
Clostridium Infections
19%
Urinary Tract Infections
18%
Pediatrics
18%
Respiratory Tract Infections
18%
Transplant Recipients
18%
Epidemiologic Studies
16%
Pneumonia
15%
Moxifloxacin
15%
Gentamicins
15%
Perfusion
14%
Ampicillin Resistance
14%
Genome
13%
Streptomycin
11%
Coronavirus
11%
Ampicillin
10%
Infection Control
10%
Pneumococcal Pneumonia
9%
Transplants
9%
Escherichia coli
9%
Infections
9%
Morbidity
8%
In Vitro Techniques
8%
Child
8%
Mortality
8%
Virulence Factors
8%
Agriculture & Biology
aspergillosis
55%
lungs
31%
Aspergillus fumigatus
25%
pneumonia
21%
Portugal
20%
vaccines
17%
serotypes
16%
loci
12%
pediatrics
11%
genotype
11%
Coronavirinae
11%
fungi
9%
acute respiratory distress syndrome
8%
infection
6%
galactomannans
5%
triazoles
5%
Earth & Environmental Sciences
pneumonia
25%
vaccine
24%
genotype
21%
hospital
18%
fungus
13%
infection
11%
comparison
8%
mortality
6%